Molecular Functions of Long Non-Coding RNAs: Implications for Diseases and Therapy
A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Biochemistry, Molecular and Cellular Biology".
Deadline for manuscript submissions: 31 July 2025 | Viewed by 767
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue concentrates on the expanding field of long non-coding RNAs (lncRNAs) and their pivotal contributions to disease pathophysiology. While lncRNAs were once viewed merely as transcriptional noise, recent findings indicate they participate in diverse cellular functions, including gene regulation, chromatin remodeling, and RNA splicing. By integrating current research and advanced methodologies, this collection of articles aims to highlight how lncRNAs modulate molecular processes in cancer, neurodegenerative disorders, cardiovascular diseases, and more. The presented studies emphasize both basic and translational research, revealing how targeting or harnessing lncRNAs might shape new therapeutic strategies. Contributors discuss emerging technologies for lncRNA profiling, functional characterization, and validation, offering a roadmap for identifying disease-specific biomarkers and tailoring targeted interventions. Overall, this Special Issue seeks to stimulate discussion on the dynamic roles of lncRNAs, catalyzing future investigations and advancing the development of innovative treatments for diverse human diseases. These advances aim to foster meaningful clinical breakthroughs.
Dr. Bodhisattwa Banerjee
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- long non-coding RNAs (lncRNAs)
- gene regulation
- molecular mechanisms
- chromatin remodeling
- epigenetic control
- disease pathophysiology
- biomarker discovery
- therapeutic strategies
- translational research
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
